Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Recipients Of Pfizer COVID-19 Vaccine Had Higher Mortality Than Those Of Moderna: Study

AlTi Global Inc. Trims Stake in Pfizer Inc. (NYSE:PFE)

Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now?
Is Pfizer Inc.'s (NYSE:PFE) Stock Price Struggling As A Result Of Its Mixed Financials?

20,593 Shares in Pfizer Inc. (NYSE:PFE) Purchased by Alteri Wealth LLC

Anson Funds Management LP Increases Stake in Pfizer Inc. (NYSE:PFE)

Freestone Grove Partners LP Invests $481,000 in Pfizer Inc. (NYSE:PFE)
A mammoth vaccination drive: Looking back at the COVID-19 pandemic - The Hindu

Pfizer (NYSE:PFE) Shares Down 1.5% - What's Next?

Aspire Growth Partners LLC Invests $592,000 in Pfizer Inc. (NYSE:PFE)

Asset Management Group Inc. Sells 5,241 Shares of Pfizer Inc. (NYSE:PFE)

Alden Global Capital LLC Invests $6.22 Million in Pfizer Inc. (NYSE:PFE)

Gallagher Fiduciary Advisors LLC Boosts Stake in Pfizer Inc. (NYSE:PFE)

Manufacturing Stocks To Watch Now - April 30th

Pfizer (NYSE:PFE) Stock Price Up 0.4% - Here's What Happened

CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics ...

Mercer Global Advisors Inc. ADV Sells 189,942 Shares of Pfizer Inc. (NYSE:PFE)

FAS Wealth Partners Inc. Sells 1,109 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Sold by Mercer Global Advisors Inc. ADV

Q1 2025 GeoVax Labs Inc Earnings Call Transcript

Arvinas (ARVN) Experiences Price Target Reduction Amid Development Shift | ARVN Stock News

South Plains Financial Inc. Buys New Shares in Pfizer Inc. (NYSE:PFE)

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2025 Earnings Call Transcript

GeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2025 Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript

FY2025 EPS Estimates for Pfizer Raised by Cantor Fitzgerald

Arvinas (ARVN) Price Target Reduced as Key Drug Trials Progress | ARVN Stock News

Wells Fargo Adjusts Target Price for Arvinas (ARVN) Stock | ARVN Stock News

Arvinas (ARVN) Downgraded to Hold Amid Vepdeg Combo Trial Cancellation | ARVN Stock News

Barclays Adjusts Price Target for Arvinas (ARVN), Maintains Positive Outlook | ARVN Stock News

Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...

Optimizing the Delivery of GI Care in Transgender and Gender-Diverse Communities | MDedge

Summit Therapeutics (SMMT) Sees Balanced Options Activity Ahead of Earnings | SMMT Stock News

Arvinas (ARVN) Halts Development of Cancer Drug with Pfizer | ARVN Stock News

3 High-Yield Dividend Stocks That Could Rally Near 52-Week Lows | Investing.com

Sulzberger Capital Advisors Inc. Makes New $312,000 Investment in Pfizer Inc. (NYSE:PFE)

Pfizer (NYSE:PFE) Stock Price Up 2% After Better-Than-Expected Earnings
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
Do Wall Street Analysts Like Pfizer Stock?

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

Becker Capital Management Inc. Cuts Stake in Pfizer Inc. (NYSE:PFE)

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp | ABNewswire

Pfizer (PFE) Rating Upgraded: Signs of Stabilization Amid Strategic Shifts

Pfizer, BioNTech Fail to Void Alnylam's Covid-Shot Patent Claims

Pfizer (NYSE:PFE) Releases Earnings Results, Beats Estimates By $0.25 EPS

Pfizer (NYSE:PFE) Trading 3.6% Higher on Earnings Beat

Pfizer Inc. (NYSE:PFE) Shares Sold by Comerica Bank

Best Manufacturing Stocks To Watch Now - April 29th

Comerica Bank Lowers Stock Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer's (PFE) Price Target Raised by UBS Analyst Despite Mixed Revenue | PFE Stock News

Pfizer (NYSE:PFE) Updates FY 2025 Earnings Guidance

Lido Advisors LLC Has $8.90 Million Stake in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Acquired by The Manufacturers Life Insurance Company
AWS preps staff for customer concerns over tariffs, data risks, and possible foreign cloud restrictions by Trump | Business Insider Africa

Pfizer Inc (PFE) Q1 2025 Earnings Call Highlights: Navigating Revenue Decline and Strategic Growth

Pfizer announces more cost-cutting and the pink tax penalising women
Pfizer's CEO Said Tariffs Stopping 'Tremendous Investments' in US - Business Insider
Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away | Business Insider Africa

Q1 2025 Pfizer Inc Earnings Call Transcript

Pfizer (PFE) Seeks Clarity on Tariff Policies to Boost U.S. Investments

Global evolution of inflammatory bowel disease across epidemiologic stages

A targeted literature review on the impact of tailored interventions on patient outcomes in oncology

Fineacre Securities Features Pfizer is suspending the development of an obesity drug -- Fineacre Securities Limited | PRLog

Updated CDC Recommendations Aim to Help Protect Millions of People 50 and Older and Adults at High Risk from Potentially Serious Lung Infection | PressReleasePoint

Untruths? Tariffs? For Pfizer CEO, Nothing Trumps National Security 04/30/2025

Health Care Climbs Amid Mixed Earnings - Health Care Roundup | Morningstar

Pfizer (PFE) Focuses on R&D and Cost Efficiency Amid Q1 Revenue Decline

Pfizer Earnings: Expected Sales Decline Met With Solid Bottom-Line Growth From Cost Savings | Morningstar

Pfizer (NYSE:PFE) Trading 1.2% Higher - Should You Buy?

Pfizer Eyes Smaller Drugmakers After Failure of Obesity Pill

Stocks on the move: Pfizer and Uber

Pfizer CEO: Trump tariff uncertainty is deterring U.S. investment

Pfizer Shares Rise After Q1 Profit Beats, Reaffirms 2025 Outlook

Best Manufacturing Stocks To Add to Your Watchlist - April 28th

Pfizer Eyes Acquisitions After Obesity Drug Setback

Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID | Morningstar

Pfizer Cuts Spending on Weaker Sales After Obesity Failure (3)

Pfizer Inc. Reports Q1 2025 Earnings: EPS of $0.52 Beats Estimates, Revenue at $13. ...

Pfizer Inc. (PFE) Files Form 8-K Report with SEC

Pfizer (PFE) Surpasses EPS Expectations but Misses Revenue Target

Pfizer (PFE) Maintains Strong Performance Despite Medicare Challenges | PFE Stock News

Pfizer (PFE) Surpasses EPS Expectations, Revenue Falls Short

Pfizer (PFE) Eyes Acquisitions After Q1 2025 Results

Pfizer (PFE) Q1 Revenue Falls Short of Expectations | PFE Stock News

Pfizer's plunging Paxlovid sales impact revenue as COVID fades | Morningstar

Pfizer Inc (PFE) Reports Q1 2025 Financial Results and Reaffirms 2025 Guidance | PFE stock news

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance | PFE Stock News

Pfizer (PFE) Beats Q1 EPS Estimates Despite Revenue Miss

Pfizer Inc. (NYSE:PFE) Shares Purchased by Northern Trust Corp
Pfizer Beats Profit Estimates on Cost Cuts, Heart Drug Sales | Newsmax.com
Pfizer beats Q1 profit estimates on cost cut, strong sale of heart drug | World News - Business Standard

Pfizer 1Q Revenue Slides as Paxlovid Sales Fade | Morningstar

Pfizer (PFE) earnings Q1 2025

Pfizer (PFE) Faces Key Earnings Test Amid Patent Challenges
PFIZER news

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Business Trends 2025: Key Insights Shaping the Future of Global Markets

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision